These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14624873)

  • 1. In vitro reconstitution of heat shock protein-peptide complexes for generating peptide-specific vaccines against cancers and infectious diseases.
    Li Z
    Methods; 2004 Jan; 32(1):25-8. PubMed ID: 14624873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of heat shock protein-peptide complexes on tumor and infectious diseases immunity].
    Meng SD; Gao F; Tien P
    Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):425-8. PubMed ID: 11051811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins.
    Wang XY; Manjili MH; Park J; Chen X; Repasky E; Subjeck JR
    Methods; 2004 Jan; 32(1):13-20. PubMed ID: 14624871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat-shock proteins as powerful weapons in vaccine development.
    Bolhassani A; Rafati S
    Expert Rev Vaccines; 2008 Oct; 7(8):1185-99. PubMed ID: 18844593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein-peptide complexes in cancer immunotherapy.
    Srivastava PK; Udono H
    Curr Opin Immunol; 1994 Oct; 6(5):728-32. PubMed ID: 7826528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells.
    Tobian AA; Canaday DH; Harding CV
    J Immunol; 2004 Oct; 173(8):5130-7. PubMed ID: 15470057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors.
    Blachere NE; Srivastava PK
    Semin Cancer Biol; 1995 Dec; 6(6):349-55. PubMed ID: 8938273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
    Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
    J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for human cancer using heat shock protein-peptide complexes.
    Srivastava PK
    Curr Oncol Rep; 2005 Mar; 7(2):104-8. PubMed ID: 15717943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins (HSPs) based anti-cancer vaccines.
    Ciocca DR; Cayado-Gutierrez N; Maccioni M; Cuello-Carrion FD
    Curr Mol Med; 2012 Nov; 12(9):1183-97. PubMed ID: 22804241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming immune tolerance to cancer by heat shock protein vaccines.
    Liu B; DeFilippo AM; Li Z
    Mol Cancer Ther; 2002 Oct; 1(12):1147-51. PubMed ID: 12481439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
    Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
    Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock proteins and cancer immunotherapy.
    Wang XY; Kaneko Y; Repasky E; Subjeck JR
    Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.
    Li R; Qian J; Zhang W; Fu W; Du J; Jiang H; Zhang H; Zhang C; Xi H; Yi Q; Hou J
    Br J Haematol; 2014 Sep; 166(5):690-701. PubMed ID: 24824351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of cancer using heat shock proteins.
    Manjili MH; Wang XY; Park J; Facciponte JG; Repasky EA; Subjeck JR
    Front Biosci; 2002 Jan; 7():d43-52. PubMed ID: 11779704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells.
    Enomoto Y; Bharti A; Khaleque AA; Song B; Liu C; Apostolopoulos V; Xing PX; Calderwood SK; Gong J
    J Immunol; 2006 Nov; 177(9):5946-55. PubMed ID: 17056519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein vaccines against cancer.
    Blachere NE; Udono H; Janetzki S; Li Z; Heike M; Srivastava PK
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):352-6. PubMed ID: 8280719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
    Radons J; Multhoff G
    Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells reactive to an inducible heat shock protein induce disease in toxin-induced interstitial nephritis.
    Weiss RA; Madaio MP; Tomaszewski JE; Kelly CJ
    J Exp Med; 1994 Dec; 180(6):2239-50. PubMed ID: 7964497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.